Frontiers in Endocrinology·YesterdayBeyond efficacy: the treatment lifecycle of incretin and multi-receptor agonistsReviewGLP-1 receptor agonistsPaper
Nutrients·28 SepTargeting the Gut-Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone OutcomesReviewPrebioticsPaper
Medical Sciences·24 SepFrom Neonatal History to Adult Cardiovascular Risk: Preterm Birth as a Lifelong Risk EnhancerReviewCardiovascular diseasePaper
International Journal of Nanomedicine·24 SepBioinspired and Biomimetic Nanocarriers: Advances in Exosomes and Cell-Membrane-Coated Systems for Therapeutic ApplicationsReviewInterventionsPaper
Preprints.org·22 AugTargeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone OutcomesPreprint: reviewInterventionsPaper
Preprints.org·19 AugTargeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone OutcomesPreprint: reviewInterventionsPaper